Literature DB >> 3395317

Modulation of cardiac impulse generation and conduction by nifedipine and verapamil analyzed by a refined surface ECG technique in Langendorff perfused guinea pig hearts.

G Stark1, U Stark, H A Tritthart.   

Abstract

Using a modified Langendorff system, a special ECG recording technique and appropriate placement of two silver wire electrodes, early atrial and His bundle activity can be detected continuously from the surface of intact and spontaneously beating guinea pig hearts. This new method was applied to measure the direct and inhibitory effects of nifedipine and verapamil on impulse generation and conduction in isolated and perfused guinea pig hearts. Depression of sinoatrial conduction was the most prominent effect of nifedipine. In all concentrations applied (10(-7) M, 10(-6) M, 10(-5) M) nifedipine predominantly led to sinoatrial blocks of different degrees. Heart rate decreased slightly in a dose-dependent manner. PQ and HV duration remained essentially constant. In the highest concentration of nifedipine (10-5) M), sinus node activity was so depressed that AV dissociation or ventricular rhythm developed. Only in one out of eight experiments with cumulative increase of nifedipine concentrations to 10(-5) M was the AV node affected by nifedipine and a second-degree AV block developed (10(-6) M). Verapamil's inhibitory effects on the rate of impulse initiation in the sinus node were more pronounced than those of nifedipine, but the inhibition of sinoatrial conduction by verapamil was less marked. At 10(-6) M verapamil, the incidence of sinoatrial blocks and of ventricular rhythm was similar to the incidence of first degree AV blocks. PQ time (+14%) but also HV time (+12%) were prolonged under the influence of this concentration of verapamil. At the highest concentration of verapamil (10(-5) M) applied for 10 min, ventricular rhythm developed in five out of eight experiments, as well as one second and two third-degree AV blocks. The results confirm that the simultaneous measurements of sinus node activity of sinoatrial and atrioventricular conduction and of HV duration is feasible with this ECG technique, to evaluate the inhibitory effects of Ca-antagonists on sinus and AV node activity in the intact heart.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3395317     DOI: 10.1007/bf01907274

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  24 in total

1.  Effects of agents which inhibit the slow channel on sinus node automaticity and atrioventricular conduction in the dog.

Authors:  D P Zipes; J C Fischer
Journal:  Circ Res       Date:  1974-02       Impact factor: 17.367

2.  Verapamil in cardiac arrhythmias.

Authors:  J R Milne; C B Boothby; C S Garrard; D Pickering
Journal:  Br Med J       Date:  1972-05-06

3.  [Isoptin in the therapy of tachycardiac type of atrial flutter].

Authors:  F Bender
Journal:  Med Klin       Date:  1967-04-21

Review 4.  Electrophysiology and pharmacology of cardiac arrhythmias. VI. Cardiac effects of verapamil.

Authors:  M R Rosen; A L Wit; B F Hoffman
Journal:  Am Heart J       Date:  1975-05       Impact factor: 4.749

5.  Effects of verapamil on sinus node function in man.

Authors:  G Breithardt; L Seipel; E Wiebringhaus; F Loogen
Journal:  Eur J Cardiol       Date:  1978-10

6.  Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine, on the sinoatrial and atrioventricular nodes. Experimental and clinical studies.

Authors:  C Kawai; T Konishi; E Matsuyama; H Okazaki
Journal:  Circulation       Date:  1981-05       Impact factor: 29.690

Review 7.  Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem.

Authors:  P D Henry
Journal:  Am J Cardiol       Date:  1980-12-01       Impact factor: 2.778

8.  [Effect of nifedipine on sinus node and atrioventricular node function following autonomic blockade in the human].

Authors:  T Pop; N Treese; W Kasper; T Meinertz; C J Schuster; G Schreiner; J Meyer
Journal:  Z Kardiol       Date:  1983-12

9.  Comparative clinical electrophysiologic effects of diltiazem, verapamil and nifedipine: a review.

Authors:  L B Mitchell; J S Schroeder; J W Mason
Journal:  Am J Cardiol       Date:  1982-02-18       Impact factor: 2.778

10.  Effects on atrioventricular conduction and blood flow of enantiomers of verapamil and of tetrodotoxin injected into the posterior and the anterior septal artery of the atrioventricular node preparation of the dog.

Authors:  K Satoh; T Yanagisawa; N Taira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-08       Impact factor: 3.000

View more
  5 in total

1.  CP-96,345, a non-peptide antagonist of substance P. III. Cardiovascular effects in mammals unrelated to actions on substance P receptors.

Authors:  J Donnerer; U Stark; H A Tritthart; F Lembeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-09       Impact factor: 3.000

2.  Comparison of acute effects of anthracyclines on cardiac electrophysiological parameters of isolated guinea-pig hearts.

Authors:  G Stark; U Stark; H Samonigg; K Kasparek; A Lueger; S Nagl; H Bertuch; E Pilger; H A Tritthart
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  Comparison of acute electrophysiological effects of amiodarone and its metabolite desethylamiodarone in Langendorff perfused guinea pig hearts.

Authors:  G Stark; U Stark; M Windisch; M Vicenzi; U Eggenreich; S Nagl; K Kral; E Pilger; H A Tritthart
Journal:  Basic Res Cardiol       Date:  1991 Mar-Apr       Impact factor: 17.165

4.  The influence of elevated Mg2+ concentrations on cardiac electrophysiologic parameters.

Authors:  G Stark; U Stark; E Pilger; K Hönigl; H Bertuch; H A Tritthart
Journal:  Cardiovasc Drugs Ther       Date:  1989-04       Impact factor: 3.727

5.  Novel Labdane Diterpenes-Based Synthetic Derivatives: Identification of a Bifunctional Vasodilator That Inhibits CaV1.2 and Stimulates KCa1.1 Channels.

Authors:  Gabriele Carullo; Simona Saponara; Amer Ahmed; Beatrice Gorelli; Sarah Mazzotta; Alfonso Trezza; Beatrice Gianibbi; Giuseppe Campiani; Fabio Fusi; Francesca Aiello
Journal:  Mar Drugs       Date:  2022-08-13       Impact factor: 6.085

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.